January 3, 2018 / 6:01 PM / 7 months ago

BRIEF-Briacell Provides Clinical Update On Its Lead Immunotherapy Drug In Advanced Breast Cancer

Jan 3 (Reuters) - Briacell Therapeutics Corp:

* BRIACELL PROVIDES CLINICAL UPDATE ON ITS LEAD IMMUNOTHERAPY DRUG IN ADVANCED BREAST CANCER

* BRIACELL -PATIENT RECRUITMENT IS ON SCHEDULE DESPITE INTERRUPTION DUE TO TEMPORARY SHUTDOWN OF SOME CLINICAL SITES, AFFECTED BY WILDFIRES, HURRICANES​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below